论文部分内容阅读
目的探析支气管哮喘急性期治疗中运用多索茶碱与盐酸氨溴索的临床效果。方法将2015年6月-2016年6月我院收治的190例支气管哮喘患者随机分为两组。对照组给予常规治疗,观察组应用盐酸氨溴索+多索茶碱联合治疗,比较分析两组疗效。结果与对照组(78.95%)比较,观察组(97.89%)治疗有效率高,组间对比差异有统计学意义(P<0.05);观察组的住院和临床症状消失时间短于对照组,组间对比差异有统计学意义(P<0.05);同时,两组Pa CO_2和Pa O_2比较差异有统计学意义(P<0.05)。结论临床上运用多索茶碱与盐酸氨溴索联合治疗支气管哮喘,不仅可以缩短治疗时间,还能提高疗效。
Objective To investigate the clinical efficacy of doxofylline and ambroxol hydrochloride in the treatment of acute asthma. Methods A total of 190 bronchial asthma patients admitted to our hospital from June 2015 to June 2016 were randomly divided into two groups. The control group was given routine treatment. The observation group was treated with ambroxol hydrochloride combined with doxofylline, and the curative effect was compared between the two groups. Results Compared with the control group (78.95%), the observation group (97.89%) had a high effective rate of treatment and the difference between the two groups was statistically significant (P <0.05). The disappearance of hospitalization and clinical symptoms in the observation group was shorter than that of the control group There was significant difference between the two groups (P <0.05). Meanwhile, there was significant difference between PaCO_2 and Pa O_2 in both groups (P <0.05). Conclusion The clinical use of doxofylline and ambroxol hydrochloride combined treatment of bronchial asthma, not only can shorten the treatment time, but also improve the curative effect.